Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
SYRE (Spyre Therapeutics, Inc.) has 4 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Prev close 90.68 · gapped below the open, then crossed back over prior close. High/low 92.04 at 4:45 pm ET, 88.99 at 10:45 am ET.
Spyre Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
264 institutional managers report a position in Spyre Therapeutics, Inc. worth $8.6B between them, filed on form 13F for the quarter ending 2026-06-30. 29 of them hold 80% of it, the largest being FMR LLC at 13.48%.
239 more managers in the register
29 managers hold 80% of the $8.6B institutional base. The other 235 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via RTW Investments, LLC, VR Adviser, LLC, Paradigm Biocapital Advisors LP +16 more · 4.40% of SYRE, 4.22% of ORKA
via RTW Investments, LLC, Paradigm Biocapital Advisors LP, Jupiter Topco LLC +14 more · 4.40% of SYRE, 6.49% of TNGX
via Paradigm Biocapital Advisors LP, VR Adviser, LLC, Jupiter Topco LLC +7 more · 3.97% of SYRE, 3.91% of JBIO
via Driehaus Capital Management LLC, Capital World Investors, Jupiter Topco LLC +13 more · 2.90% of SYRE, 5.72% of DFTX
via Perceptive Advisors LLC, Driehaus Capital Management LLC, Jupiter Topco LLC +7 more · 4.47% of SYRE, 7.20% of AMLX
via Driehaus Capital Management LLC, Jupiter Topco LLC, Franklin Resources Inc +11 more · 2.90% of SYRE, 4.33% of XENE
Managers holding a meaningful stake in SYRE also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.